
About LGC Group
Biosearch Technologies Oligo Synthesis provides tailored oligonucleotide synthesis and advanced nucleic acid chemistry solutions that enable customers to design, develop, and scale high-performance nucleic acid products from early research through commercialisation. Our three global oligonucleotide manufacturing sites ensure nanomole to gram scale quantities with consistent quality and streamlined scalability for early-stage development through to commercialisation. By overseeing raw material production, including our best-in-class Black Hole Quencher™ (BHQ™) and proprietary fluorophores that span the full visible spectrum, we guarantee supply chain security with unmatched product support. Serving customers across the nucleic acid testing (NAT) and molecular diagnostics (MDx) markets, Biosearch Technologies Oligo Synthesis empowers scientists and diagnostics developers to bring accurate, robust, and scalable nucleic acid–based solutions to market with confidence.



